| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Sep 5, 2025 | Nautilus Biotechnology, Inc. | General Counsel | Buy | 91.3 | +20,000 | 36.11% | ✗ | $12.9K |
| Aug 12, 2022 | Aug 16, 2022 | Nautilus Biotechnology, Inc. | General Counsel | Buy | 91.3 | +10,000 | 22.03% | ✗ | $28.4K |
| Aug 13, 2021 | Aug 13, 2021 | Nautilus Biotechnology, Inc. | General Counsel | Buy | 91.3 | +5,000 | 17.16% | ✗ | $37.8K |